BIS Company Profile and Key Details

NASDAQ : BIS

ProShares - UltraShort Nasdaq Biotechnology

$11.27

-0.2316-2.01%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

ProShares - UltraShort Nasdaq Biotechnology (BIS) stock declined over -2.01%, trading at $11.27 on NASDAQ, down from the previous close of $11.50. The stock opened at $11.46, fluctuating between $11.24 and $11.64 in the recent session.

Stock Snapshot

11.4972

Prev. Close

1.81M

Market Cap

11.235

Day Low

N/A

P/E Ratio

N/A

EPS (TTM)

N/A

Cash Flow per Share

11.46

Open

160.32K

Number of Shares

11.64

Day High

N/A

Free Float in %

N/A

Book Value

5.89K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 24, 2026	11.43	11.57	11.26	11.27	5.89K
Sep 23, 2026	11.01	11.59	11.01	11.50	5.77K
Sep 21, 2026	11.51	11.54	11.50	11.53	3.95K
Sep 18, 2026	11.64	11.79	11.64	11.79	1.97K
Sep 17, 2026	11.74	11.74	11.44	11.49	10.83K
Sep 16, 2026	11.92	12.11	11.83	12.04	5.81K
Sep 15, 2026	12.07	12.12	12.07	12.10	5.49K
Sep 14, 2026	11.91	11.91	11.68	11.76	5.96K
Sep 11, 2026	11.85	11.96	11.76	11.96	4.48K
Sep 10, 2026	11.90	12.01	11.74	11.99	8.17K
Sep 09, 2026	11.44	11.64	11.44	11.64	4.59K
Sep 08, 2026	11.28	11.60	11.28	11.45	7.47K
Sep 04, 2026	10.98	10.98	10.97	10.97	981
Sep 03, 2026	10.70	10.98	10.70	10.79	11.79K
Sep 02, 2026	10.95	11.13	10.66	10.81	10.41K
Sep 01, 2026	11.24	11.25	11.11	11.11	8.49K
Aug 31, 2026	11.55	11.55	11.22	11.31	6.07K
Aug 28, 2026	10.88	11.34	10.88	11.31	7.27K
Aug 27, 2026	10.76	10.76	10.68	10.72	3.08K
Aug 26, 2026	10.63	10.71	10.61	10.65	7.24K

Contact Details

Bethesda, MD 20814

United States

https://www.proshares.com/our-etfs/leveraged-and-inverse/bis 186 677 65125

About Company

The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.

Stock Peers

RYVLX

-0.07-0.01%

Rydex NASDAQ-100 2x Strategy Fund$904.49 RYVYX

-0.07-0.01%

Rydex NASDAQ-100 2x Strategy Fund Class H$904.16 RYCCX

-0.06-0.01%

Rydex NASDAQ-100 2x Strategy Fund$608.10 AMUU

14.0228+4.95%

Direxion Daily AMD Bull 2X ETF$297.15 RYLDX

-1.43-0.65%

Rydex Dow 2x Strategy Fund Class A$218.38 RYCVX

-1.42001-0.65%

Rydex Dow 2x Strategy Fund Class H$217.48 LINT

13.01+7.74%

Direxion Daily INTC Bull 2X ETF$181.12 RYCYX

-1.16-0.65%

Rydex Dow 2x Strategy Fund$177.40 GLDI

-0.41-0.28%

UBS AG ETRACS Gold Shares Covered Call ETNs due February 2, 2033$144.02 AMDG

6.7291+4.96%

Leverage Shares 2x Long AMD Daily ETF$142.48

Company Overview

ProShares - UltraShort Nasdaq Biotechnology (NASDAQ:BIS) closed at $11.27 USD, losing -$0.23 (-2.01%) from the previous close of $11.50. The stock is currently mid-range between its 52-week high and low $10.51 and $28.20. With a market capitalization of about $1.81 million, ProShares - UltraShort Nasdaq Biotechnology is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.19). Key stats such as the average daily volume over the past year has been around 7.67 thousand shares, in line with its 52-week average. Headquartered in Bethesda, MD, ProShares - UltraShort Nasdaq Biotechnology operates in the Financial Services sector and the Asset Management - Leveraged industry. Led by CEO , the company employs approximately 98 people and listed since April 09, 2010. The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 -1.39%, SMA50 -4.75%, SMA200 -33.8%). The stock’s 14-day RSI is 45.45 (neutral), while the ATR of 0.24 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -66.91% below its high and over 3.07% above its low. Average 10-day trading volume of 5.71 thousand shares is below the 3-month average of 7.78 thousand, indicating normal recent market interest.

Dividend & Fair Value

ProShares - UltraShort Nasdaq Biotechnology last paid a dividend of 0.79 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that ProShares - UltraShort Nasdaq Biotechnology stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

currently trading near 52-week highs band.

Frequently Asked Questions

What is the current ProShares - UltraShort Nasdaq Biotechnology (BIS) stock price?

ProShares - UltraShort Nasdaq Biotechnology (NASDAQ: BIS) stock price is $11.27 in the last trading session. During the trading session, BIS stock reached the peak price of $11.64 while $11.24 was the lowest point it dropped to. The percentage change in BIS stock occurred in the recent session was -2.01% while the dollar amount for the price change in BIS stock was - $0.23.

BIS's industry and sector of operation?

The NASDAQ listed BIS is part of Asset Management - Leveraged industry that operates in the broader Financial Services sector. ProShares - UltraShort Nasdaq Biotechnology designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BIS?

No Data

How BIS did perform over past 52-week?

BIS's closing price is 7.19% higher than its 52-week low of $10.51 where as its distance from 52-week high of $28.20 is -60.05%.

How many employees does BIS have?

Number of BIS employees currently stands at 98.

Link for BIS official website?

Official Website of BIS is: https://www.proshares.com/our-etfs/leveraged-and-inverse/bis

How do I contact BIS?

BIS could be contacted at phone 186 677 65125 and can also be accessed through its website. BIS operates from 7501 Wisconsin Avenue, Suite 1000E, Bethesda, MD 20814, United States.

How many shares of BIS are traded daily?

BIS stock volume for the day was 5.89K shares. The average number of BIS shares traded daily for last 3 months was 7.67K.

What is the market cap of BIS currently?

The market value of BIS currently stands at $1.81M with its latest stock price at $11.27 and 160.32K of its shares outstanding.

Employees	98
Beta	-1.19
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Financial Services
Industry	Asset Management - Leveraged

BIS Company Profile and Key Details

ProShares - UltraShort Nasdaq Biotechnology

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook